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The stoichiometric omplex formed between bovine j?-trypsin and the Cucurbita maxima trypsin inhibitor I (CMTI-I) 
was crystallized and its X-ray crystal structure determined using Patterson search techniques. Its structure has been crystal- 
lographically refined to a final R value of 0.152 (6.0 - 2.0 A). CMTI-I is of ellipsoidal shape; it lacks helices or B-sheets, 
but consists of turns and connecting short polypeptide stretches. The disulfide pairing is CYS-31-201, Cys-101-221 and 
Cys-161-281. According to the polypeptide fold and disulfide connectivity its structure resembles that of the carboxypep 
tidase A inhibitor from potatoes. Thirteen of the 29 inhibitor residues are in direct contact with trypsin; most of them 
are in the primary binding segment Val-21 (P4) - Glu-91 (P4’) which contains the reactive site bond Arg-51 - Be-61 and 
is in a conformation observed also for other serine proteinase inhibitors. 
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1. INTRODUCTION 
Squash proteinase inhibitors form a group of 
small single-chain proteins (29-32 amino acid 
residues) thus far exclusively isolated from the 
seeds of the Cucurbitaceae family [l-4]. On the 
basis of amino acid sequence, reactive site location 
and half cystine content they were established as a 
new family of serine proteinase inhibitors [5-S]. 
They are the smallest known protein inhibitors of 
serine proteinases, are very resistant against heat 
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residues are indicated by an 1 after the residue number 
or acid denaturation and exhibit strong inhibition 
towards trypsin. The reactive site peptide bond was 
located in the amino-terminal part of the molecule 
between Arg-51 or Lys-51 and Ile-61 [9]. 
CMTI-I is a characteristic representative of the 
squash inhibitors. It was originally found in seeds 
of pumpkin (Cucz&~ta maxima), but later also in 
seeds of figleaf gourd (Cucurbita ficifolia) [l]. 
CMTI-I consists of 29 amino acid residues [5] with 
Arg-51 (Pl) and Ile-61 (Pl ‘) constituting the reac- 
tive site bond. It binds to bovine &trypsin with an 
association constant of 3.2 x 10” M-’ [6]. 
The spatial structure of the squash seeds in- 
hibitors has not yet been elucidated and the 
disulfide connectivity remained undetermined. In 
the following we report the crystal structure of a 
complex of CMTI-I formed with bovine ,&trypsin. 
The detailed structure and a comparison with 
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related complexes will be communicated 
elsewhere. 
2. MATERIALS AND METHODS 
CMTI-I was isolated from the seeds of C. ficifoliu and 
purified as described [lo]. Bovine ,&trypsin was purified from 
commercial trypsin (Merck, Darmstadt) [11,12]. A 
stoichiometric omplex between CMTI-I and bovine ,&trypsin 
was formed by adding both components at a 1.2: 1 molar ratio 
(5 x 10e4 M). This complex crystallized at 20°C in 20% po- 
ly(ethylene glycol) 6000 (Serva, Heidelberg), buffered with 
0.1 M phosphate to pH 4-5, using the hanging drop vapour dif- 
fusion technique. The crystals are of orthorhombic space group 
P2t2r2t; the cell constants are a = 59.28 A, b = 55.47 A, c = 
74.59 A, (Y = /3 = y = 90”. The crystals contain one (complex) 
molecule per asymmetric unit and diffract to almost 1.8 A 
resolution, 
X-ray intensity data were collected with a FAST television 
area detector diffractometer (Enraf-Nonius, Delft) using a 
crystal-to-detector distance of 40.5 mm and a detector angle of 
10”. One single crystal was mounted in 2.5 M phosphate buffer, 
pH 5, and rotated for 95” about o* and about an axis 30” obli- 
que to a*, respectively. The reflection data (table 1) were 
evaluated on-line using the program MADNES [13]. The data 
were corrected for absorption effects using equivalent reflec- 
tions to determine the absorption ellipsoid of the crystal (using 
programs of R. Huber and M. Schneider following the 
theoretical analysis presented [14]) whereafter the Friedel mates 
were independently averaged and by means of PROTEIN [15] 
loaded and averaged (table 1). 
The orientation of the trypsin component was determined by 
the rotation function in Patterson space using a model Patter- 
son map (2500 highest peaks, 3-15 A shell) calculated with the 
refined bovine trypsin model [16] and the crystal Patterson map 
(calculated with intensity data from 8 to 3.5 A). The highest 
peak corresponding to the correct solution was 7u above the 
mean. The positioning of the trypsin molecule in the unit cell 
was achieved by a translation function search with programs 
written by E.E. Lattmann (modified by J. Deisenhofer and R. 
Huber), and using intensity data from 8 to 3.5 A. The transla- 
tion function showed highest peaks in the three Harker sections 
at consistent locations. The rotational and translational 
parameters were further refined with the Fourier transform fit- 
ting program TRAREF [17]. 
A 3 A 2F, - F, Fourier map calculated with Sim-weighted 
Table 1 
Reflection data 
Maximal resolution 
Number of measurements 
R me**e a after scaling and absorption correction 
Rmcrgca of Friedel mates 
Number of independent reflections 
Measured/possible reflections to 2 A 
aR merge = mz- cn)/Cz 
2.0 A 
54 864 
0.073 
0.036 
14 191 
0.81 
286 
Table 2 
Final model parameters of the CMTI-trypsin structure 
Number of active protein atoms 
Number of inactive protein atoms 
Number of active solvent atoms 
rms standard deviation from target values 
Bond lengths 
Bond angles 
Total internal energy 
Resolution range 
Number of unique reflections used for 
refinement 
R value 
Mean B value 
Lower B value limit 
Estimated mean coordinate error from 
agreement between observed and calcu- 
lated structure factors 
According to Luzzati [34] 
According to Cruickshank [35] 
1818 
16 
140 
0.020 A 
2.70” 
1325 kcal/mol 
6.0-2.0 A 
13077 
0.151= 
15.0 A2 
3.0 A2 
0.18 A 
0.14 A 
a Rejecting 1.5% of all reflections with 2 
(IF,1 - IF,I)/(IF,I + IF,I) > 1.2 
model phases displayed the trypsin molecule and in addition 
showed electron density representing the inhibitor. The com- 
plete CMTI-I polypeptide chain was modeled into the electron 
density on a PS330 interactive display (Evans and Sutherland) 
using the PSFRODO version [ 181 of FRODO [ 191. The enzyme- 
inhibitor model was refined within 7 macrocycles using the 
energy restraint crystallographic refinement EREF [20] and 
energy parameters mentioned recently [21]; all non-bonded 
restraint parameters for Ser-195 07 were set to zero to allow its 
unbiased approach to the reactive site bond of the inhibitor. 
Between every two macrocycles Fourier and difference Fourier 
maps were inspected at the graphics display to correct gross 
model errors. 
The intensity data used were gradually extended to 2.0 A 
resolution. Solvent molecules were inserted at stereochemically 
reasonable positions if the difference electron density exceeded 
4~. Finally, individual B values were also refined. The final R 
value (defined as c( I I FO I - IF, I I )/c I F, I for 13 077 reflec- 
tions between 6.0 and 2.0 A resolution is 0.151. The final 
refinement characteristics are given in table 2. 
3. RESULTS 
Fig. 1 shows an a-carbon drawing of the CMTI- 
I-bovine trypsin complex, with the inhibitor bound 
to the substrate binding cleft and projecting from 
the enzyme as a relatively small hump. The trypsin 
chain can be completely traced in the Fourier map 
from Ile-16 down to Asn-245, with only 12 side 
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Fig. 1. a-Carbon drawing of the complex formed between bovine ,&rypsin (thin connections) and CMTI-I (bold connections). For sake 
of simplicity, only the residues of the tryptic active site triad, Asp-189 (S-pocket) and the C-terminal Asn-245 of trypsin and 
PI-residue Arg-51 of CMTI-I are given in full detail. 
chain atoms remaining undefined due to higher 
mobility. Main chain segments 74-79 (forming 
part of the ‘calcium-loop’ in trypsin [16]), 146-149 
(being part of the ‘autolysis loop’ which contains 
the primary cleavage site for autodigestion [l 11) 
and 243-245 (carboxy terminus) exhibit B values 
significantly above the mean. The ‘calcium-site’ is 
only very weakly occupied (interpreted as solvent 
molecule Sol-944, with extremely short contacts to 
Val-75 0); the low occupancy gives rise to the 
relatively large disorder of this loop [16]. The tryp- 
sin conformation is very weakly affected by in- 
hibitor binding or by the different cell contacts; the 
rms deviation of all a-carbon atoms of the trypsin 
component compared with free or benzamidine 
liganded bovine trypsin is 0.34 A, i.e. only slightly 
above the estimated coordinate errors (table 2). As 
usually observed for serine proteinase complexes 
the active site residues and most segments compris- 
ing the binding site are optimally superimposable. 
All internal and many of the surface bound solvent 
molecules occupy identical positions. 
The inhibitor (fig.2) roughly exhibits the shape 
of a flat-iron, with the base plate made up of the 
polypeptide chain from Met-81 on, and the grip 
formed by the protruding reactive site loop con- 
taining the scissile peptide bond Arg-SI-Ile-61. 
The essentially hydrophobic side chains of this 
loop (Pro-41, Ile-61, Leu-71, Met-U) make up 
together with Val-21, Tyr-271, Leu-171 and Ala-181 
a curved shell of hydrophobic surface, which 
passes over continuously into the hydrophobic 
core formed by the adjacent disulfide bridges 
traversing the center of the molecule. The half-side 
open cavity of mixed hydrophobic and polar 
character is filled with 3 strongly fixed solvent 
molecules of extremely low B values, namely 
Sol-919, Sol-808, and Sol-915 which might be con- 
sidered as integral constituents of the structure 
(fig.2). The molecular surface of the inhibitor op- 
posite to the binding loop comprises more polar 
and charged residues; a few loop segments, such as 
the relatively mobile turn around Glu-241 and 
His-251, emerge from the surface. 
With the exception of two tight turns the in- 
hibitor polypeptide chain lacks any regular extend- 
ed secondary structure elements. Due to main 
chain conformation and intramolecular hydrogen 
bonding, the inhibitor peptide chain can be sub- 
divided into the following segments (fig.3): (i) the 
extended curved proteinase binding loop 
Arg-lI-Met-81; (ii) an extended segment 
Met-81-Lys-111; (iii) a short irregular 3ro-helix of 
1% turns from Lys-121 to Cys-161; (iv) a type-II 
tight turn from Leu-171 to Cys-201; (v) segment 
Cys-201-Leu-231 of extended conformation; (vi) a 
tight turn of approximately type I from Leu-231 to 
Gly-261; (vii) the extended carboxy-terminal seg- 
ment Gly-261-Gly-291. 
Type II’-turns usually have glycines at their se- 
cond positions [22]; indeed, Ala-181 in the 
Leu-171-Cys-201 turn is outside of the normally 
287 
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Fig.2. Complete structure of CMTI-I. Main chain atom connections and disulfide bridges are emphasized by bold lines. Only the 
‘internal’ solvent molecules Sol-808, Sol-915 and Sol-919 are shown. 
‘allowed’ &$-region and in a strained conforma- 
tion (4 = 55”, + = - 127”). 
There are only a few intramolecular hydrogen 
bonds in CMTI-I (fig.3). All parts of the polypep- 
tide chain, including the amino and the carboxy 
termini, are rather uniformly crosslinked with one 
*..* *...* .** * . . . . . . . . . :r..:: .. . . . ** . ..* 
Fig.3. Schematic representation of the polypeptide arrangement 
of CMTI-I and its disulfide connectivities. Inter-main-chain 
hydrogen bonds displayed by dashed lines were selected 
according to definitions (using energy cut-off values of 
_ 1.0 kcal/mol) given by Kabsch and Sander [36]. The arrow 
indicates the scissile peptide bond. 
288 
another through the three disulfide bridges (figs 2 
and 3). The disulfide pairing is Cys-31-Cys-201, 
Cys-lOI-Cys-221 and Cys-161-Cys-281, i.e. the 
three cysteine residues of the amino-terminal half 
are connected with those of the carboxy terminal 
half in identical order. The first two disulfide 
bridges are of right-handed, the third one is of left- 
handed conformation. All three disulfide bridges 
are arranged side by side, with Cys-161-Cys-281 
located in the middle. 
The amino and the carboxy-terminal ends are 
localized at the same side of the inhibitor molecule, 
but still almost 10 A apart from one another 
(fig.2). The amino terminus points away from the 
molecule and lacks any visible hydrogen bond 
partner. The side chain of Arg-11 is bent 
backwards to the molecular center; its guanidyl 
group counterbalances the carboxylate group of 
Gly-291 and forms slightly asymmetrically two 
hydrogen bonds. The Arg-11 side chain is further 
hydrogen bonded (through Glu-191 0) with seg- 
ment Glu-191-Val-211, which in turn is connected 
through two hydrogen bonds with Gly-291 (see 
fig.3). In this way amino and carboxy termini are 
fixed to the molecular core; the compact structure 
may further contribute to the resistance against 
proteolytic attack by exoproteases. On the op- 
posite side of the inhibitor molecule Asp-151 is 
likewise engaged in a surface-located salt bridge 
with the side chain of Lys-121, and simultaneously 
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Fig.4. j%Trypsin-CMTI-I interface. Polypeptide chain segments of CMTI-I are given by bold lines, trypsin segments by thin lines. 
suitably placed to counterbalance the amide 
dipoles of Lys-111 and Lys-121 (see fig.2). 
The proteinase binding loop of CMTI-I is be- 
tween Cys-31 (P3) and Met-81 (P3’) in a .similar 
conformation to that observed in the other ‘small’ 
serine proteinase protein inhibitors known so far 
[21,23], whereas the remainder of CMTI-I is 
organized in a completely different fold. The rms 
deviation of the a-carbon atoms from Cys-31 to 
Leu-71 compared with the equivalent atoms of 
ArglS-BPTI in the trypsinogen complex 1241 is, for 
example, 0.56 A. The CMTI-I reactive site loop 
appears to be tensed between disulfide bridges 
Cys-31-Cys-201 and Cys-IOI-Cys-221. Its central 
part, around the intact scissile peptide bond 
Arg-SI-Ile-61, is linked via Sol-919 (fig.2) with the 
center of the molecule. In this respect the squash 
inhibitors differ from the other inhibitors where 
the reactive site is clamped to the core through 
main or side chain hydrogen bond interactions. 
Sol-919 in CMTI-I occupies a site equivalent to 
Asn-331 N62 in ovomucoid third domains [25]. 
Fig.4 gives a section of the CMTI-I-trypsin inter- 
face. There are 138 intermolecular nonhydrogen 
atom-atom contacts below 4.0 A, all but 7 made 
by the 8 residues Arg-11 to Leu-71 and Glu-91 of 
the primary binding segment. The few residual 
contacts are made by the carboxy-terminal residues 
His-251 to Gly-291. The main chain atoms from 
Cys-31 to Met-81 exhibit (besides all cysteine 
residues) the smallest B values observed in the 
whole inhibitor molecule. In almost half of the 
contacts PI-residue Arg-51 is involved. Its side 
chain is accommodated in the Sl-pocket of trypsin 
virtually identical to the geometry observed for 
Arg-151 in the Arg 15-BPTI-trypsinogen complex 
1241, with its distal guanidyl group engaged in a 
salt bridge with Asp-189 and further hydrogen 
bonded to Gly-219 0 and to an internal solvent 
molecule (Sol-416). As usually observed in serine 
proteinase-inhibitor complexes the primary 
binding segment of CMTI-I runs antiparallel to 
trypsin segment Ser214-Gly216, and intermole- 
cular main chain-main chain hydrogen bonds are 
possible between Cys-31 (P3) and Gly-216, between 
Arg-51 (Pl) and Ser-214, Gly-193 and Ser-195, and 
between Leu-71 and Phe-41. Remarkable is the 
weakness of the first hydrogen bond pair at P3-S3 
and the relatively short and stereochemically 
favourable hydrogen bond between Arg-51 N and 
Ser-214 0. In agreement with the observation for 
other complexes, the scissile peptide bond 
Arg-SI-Red1 is intact and almost planar, and its 
carbonyl carbon is in van der Waals contact with 
Ser-195 Oy (fig.4). 
4. DISCUSSION 
This crystal structure analysis for the first time 
revealed the spatial organization of the polypep- 
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tide chain of a squash seed inhibitor. In agreement 
with proposals derived from CD-measurements 
[26], these inhibitors lack any regular secondary 
structure elements. Similar to the other ‘small’ 
protein inhibitors directed against serine pro- 
teinases, the ‘primary’ binding segment (around 
the reactive site bond Arg-SI-Ile-61) protrudes 
from the main molecular body in a characteristic 
conformation allowing an intimate contact with 
the cognate enzyme. In spite of different size and 
fold of the squash inhibitors the interaction pat- 
tern is similar to that observed in other related 
complexes. 
A remarkable feature of CMTI-I is the ion pair 
interaction of the Arg-11 side chain with the car- 
boxy terminus and the hydrogen bond linkage of 
both groups to the molecular core. In contrast to 
inhibitors isolated from Cucurbita seeds (i.e. with 
an Arg-lI), all inhibitor species from Cucumis 
seeds analyzed so far possess a methionine residue 
at the homologous position 1. These natural 
variants offer the possibility to estimate the 
significance of the salt bridge. According to ‘H- 
NMR studies [27) the inhibitors from Cucurbita 
seem to be more rigid than those from Cucumis, in 
agreement with the idea that this salt bridge pro- 
motes stability. This hypothesis might be further 
tested by following the thermal denaturation of 
these different inhibitor species or by a comparison 
of the thermal behaviour of Lys-SI-containing in- 
hibitors from Cucurbita before and after arginine 
modification by means of cyclohexanedione [lo]. 
101 
On the other hand, the inhibitors from Cucumis 
seeds (i.e. with Met-11) or variants with elongated 
carboxy termini [6] exhibit comparable inhibitory 
activity, indicating that salt bridge formation is not 
essential for function. The elongated variants fre- 
quently observed [6] let one assume that the 29-mer 
studied here is the result of posttranslational trim- 
ming at one or both ends. 
An important contribution to stability of these 
small inhibitors comes from the three disulfide 
bridges, which knit together all parts of the 
polypeptide chain. This structure analysis 
established the correct disulfide connectivity with 
the first three cysteine residues being covalently 
linked with the last three in consecutive order (this 
disulfide pairing has now been independently con- 
firmed by mass spectroscopy by Stachowiak, 
Otlewski, Polanowski and Dyckes, manuscript in 
preparation). Led by the number and sequence of 
these cysteines, Siemion et al. [27] had speculated 
about the possible similarity with each of the four 
domains of wheat germ agglutinin isolectin 2 [28]. 
CMTI-I exhibits an identical disulfide pairing for 
the first six cysteines (in disagreement with the con- 
nectivity proposed for squash seed inhibitors [27]) 
and a very weak topological resemblance of the 
amino-terminal half of CMTI-I with part of the 
first wheat germ agglutinin domain and with a few 
other structurally related ‘four-disulfide core pro- 
teins’ [29]. 
Much more evident (figS), in contrast, is the 
structural relation of CMTI-I with the carboxypep- 
Fig.5. a-Carbon drawing of CMTI-I (bold lines) overlaid with the CPI model (30) (thin lines). The disulfide bridges of both models 
are indicated, and Pl-residue Arg-51 is shown with all nonhydrogen atoms. 
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tidase A inhibitor from potatoes (CPI) [30]. In 
particular, the six cysteine residues and the connec- 
ting disulfide bridges occupy quite analogous posi- 
tions in both molecules; the rms deviation of the 
corresponding six a-carbon atoms amounts to 
1.8 A. From the second cysteine on (Cis-101 in 
CMTI-I), the polypeptide fold is quite similar. The 
amino-terminal reactive site loop of the squash 
seed inhibitors finds no counterpart in CPI; the 
CPI-chain exhibits here a less prominent loop. On 
the other hand, the CPI chain is elongated on both 
ends, with the carboxy terminus being the ex- 
oprotease binding site (301. A sequence alignment 
made according to the superposition shown in fig.5 
yields (besides the six cysteines) only four identical 
residues. The topological similarity nevertheless 
suggests a common evolutionary origin of both 
molecules. 
The squash inhibitors seem to be particularly at- 
tractive candidates for remodeling their affinity 
and specificity properties. Their small size makes 
them well suited for total chemical synthesis. 
CMTI-III has previously been made by solid-phase 
synthesis methods [31]. Very recently a Pl-valine 
analogue of CMTI-III was synthesized which ex- 
hibited high inhibitory activity towards human 
leukocyte elastase [32]. The fit to this latter enzyme 
of tremendous therapeutical interest is conceivable 
from a hypothetical complex modeled with the 
leucocyte elastase structure [33 1. Analogous ex- 
changes could yield inhibitors of still different 
specificity. Knowing the detailed interaction with 
cognate enzymes, residues more remote from the 
reactive site could be changed in a systematic man- 
ner, yielding inhibitors with improved affinity pro- 
perties or higher selectivity. Alternatively, the 
squash seed inhibitor chain could be elongated on 
the carboxy terminus to make it a carboxypep- 
tidase inhibitor. Generally these inhibitors could 
be utilized as simple design motives to create new 
functions. 
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